Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Platelet-Associated Antibodies By Flow Cytometry in Adult Patients with Immune Thrombocytopenia before and after Splenectomy

Kseniya A. Nikiforova, Elena K. Egorova, MD PhD, Yuliya O. Davydova, Nikolay M. Kapranov, Elena I. Pustovaya, MD PhD, Olga A. Soboleva, Irina V. Galtseva, MD PhD, Anait L. Melikyan, MD PhD, Karen I. Ntanisian, MD PhD, Valeriy G. Savchenko, MD PhD

Blood (2020) 136 (Supplement 1): 4–5.

https://doi.org/10.1182/blood-2020-140945

Published: 2020

Journal Articles

Stromal Precursors in the Bone Marrow of Untreated Patients with Severe and Non-Severe Aplastic Anemia Differ in the Proliferative Potential

Irina N. Shipounova, PhD, Alyona I. Dorofeeva, Nikolay M. Kapranov, Anton V. Luchkin, MD, Zalina T. Fidarova, MDPhD, Elena A Mikhailova, PhD MD, Valeriy G. Savchenko, MD PhD

Blood (2020) 136 (Supplement 1): 10.

https://doi.org/10.1182/blood-2020-139286

Published: 2020

Journal Articles

Impact of Minimal Residual Disease Detected By Multiparameter Flow Cytometry on Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia Patients in First Complete Remission

Zoya V. Konova, Elena N. Parovichnikova, MD PhD, Irina V. Galtseva, MD PhD, Nikolay M. Kapranov, Julia O. Davydova, Mikhail Yu. Drokov, MD PhD, Maria V. Nareyko, MD, Natalia N. Popova, MD, Anna A. Dmitrova, MD, Ulyana V. Maslikova, MD, Olga S. Starikova, MD, Ekaterina I. Usikova, MD, Ekaterina D. Mikhaltsova, MD PhD, Olga M. Koroleva, MD, Vera A. Vasilyeva, MD PhD, Tatiana I. Lobanova, MD, Larisa A. Kuzmina, MD PhD, Valeriy G. Savchenko, MD PhD

Blood (2019) 134 (Supplement_1): 4562.

https://doi.org/10.1182/blood-2019-123528

Published: 2019

Journal Articles

Primary Antigen Aberrations and Immunophenotype Shifts of Blasts in AML Patients during the Treatment and at the Time of Relapse

Tatiana I. Lobanova, MD, Elena N. Parovichnikova, MD PhD, Irina V. Galtseva, MD PhD, Vera V. Troitskaya, MD PhD, Julia O. Davydova, Nikolay M. Kapranov, Andrey N. Sokolov, MD PhD, Sergei M. Kulikov, PhD, Valery G. Savchenko, MD PhD academician

Blood (2019) 134 (Supplement_1): 5183.

https://doi.org/10.1182/blood-2019-128650

Published: 2019

Journal Articles

Oligoclonal Expansion and T-Cells Subpopulations in Patients with Aplastic Anemia at Different Stages of the Disease

Anastasia V. Abramova, MD, Elena A. Mikhaylova, MD PhD Prof, Zalina T. Fidarova, MD PhD, Yuliya O. Davydova, Nikolay M. Kapranov, Tatiana I. Lobanova, MD, Anton V. Luchkin, MD, Alina E. Krasilnikova, Resident Physician, Roman V. Tivikov, MD, Vera V. Troitskaya, MD PhD, Irina V. Galtseva, PhD, Elena N. Parovichnikova, MD PhD, Valery G. Savchenko, MD PhD academician

Blood (2018) 132 (Supplement 1): 3864.

https://doi.org/10.1182/blood-2018-99-119414

Published: 2018

Journal Articles

Alterations in the Properties of MSCs in Patients with Diffuse Large B-Cell Lymphoma (DLBCL) without Bone Marrow Involvement

Ekaterina Fastova, Aminat U. Magomedova, MD PhD, Nataliya Petinati, MD PhD, Natalia Sats, PhD, Nina Drize, PhD, Nikolay M. Kapranov, Julia Davydova, Irina Malyants, Viktoria Shendler, PhD, Georgiy Arapidi, PhD, Maria Lagarkova, PhD, Sergey K. Kravchenko, MD PhD, Valeriy G. Savchenko, MD PhD

Blood (2018) 132 (Supplement 1): 5309.

https://doi.org/10.1182/blood-2018-99-112040

Published: 2018

Journal Articles

The Effectiveness of Eltrombopag at the Different Stages of Aplastic Anemia and Probability of Clonal Expansion

Anton V. Luchkin, MD, Elena A. Mikhaylova, MD PhDProf, Zalina T. Fidarova, MD PhD, Anastasia V. Abramova, MD, Vera V. Troitskaya, MD PhD, Tatiana I. Lobanova, MD, Alina E. Krasilnikova, Resident Physician, Irina V. Galtseva, PhD, Yuliya O. Davydova, Nikolay M. Kapranov, Tatiana N. Obukhova, MD PhD, Lubov Grebenyuk, MD, Murat Vagida, MD, Elena N. Parovichnikova, MD PhD, Valery G. Savchenko, MD PhD academician

Blood (2018) 132 (Supplement 1): 5108.

https://doi.org/10.1182/blood-2018-99-118738

Published: 2018

Journal Articles

Different Treatment Regimens, Optimal Time Points and Threshold Level While Minimal Residual Disease Evaluation in AML Patients

Tatiana I. Lobanova, MD, Irina V. Galtseva, PhD, Yuliya O. Davydova, Nikolay M. Kapranov, Vera V. Troitskaya, MD PhD, Irina A. Lukyanova, MD, Elena Parovichnikova, MD PhD, Sergei M. Kulikov, PhD, Larisa Kuzmina, PhD, Valery G. Savchenko, MD PhD academician

Blood (2018) 132 (Supplement 1): 2808.

https://doi.org/10.1182/blood-2018-99-114669

Published: 2018

Journal Articles

The MRD-Negativity Rate Measured By Flow Cytometry after the 1 st and the 2 nd Induction Course Among CR AML Patients from Different Cytogenetic Subgroups Does Not Differ Though the Morphological CR Achievement Does

Elena Parovichnikova, MD PhD, Vera V. Troitskaya, MD PhD, Irina V. Galtseva, PhD, Tatiana I. Lobanova, MD, Yuliya O. Davydova, Nikolay M. Kapranov, Andrey N. Sokolov, MD, Alina V. Kokhno, MD, PhD, Roman V. Tivikov, MD, Irina A. Lukyanova, MD, Tatiana N. Obukhova, MD PhD, Valery G. Savchenko, MD PhD academician

Blood (2018) 132 (Supplement 1): 1495.

https://doi.org/10.1182/blood-2018-99-116581

Published: 2018

Journal Articles

Optimal Dose Horse Antithymocyte Globulin for the Treatment of Adult Patients with Aplastic Anemia: A Prospective Randomized Comparative Study

Zalina T. Fidarova, MDPhD, Elena A. Mikhaylova, MDPhDProf, Elena N. Ustinova, PhD, Vera V. Troitskaya, MD PhD, Anastasia V. Abramova, MD, Anna A. Sidorova, MD, Galina Baskhaeva, MD, Tatiana I. Lobanova, MD, Ksenija I. Zarubina, MD, Irina V. Galtseva, MD PhD, Julia O. Davydova, Nikolay M. Kapranov, Elena N. Parovichnikova, MD PhD, Valeriy G. Savchenko

Blood (2017) 130 (Supplement 1): 4957.

https://doi.org/10.1182/blood.V130.Suppl_1.4957.4957

Published: 2017

Journal Articles

Absolute Lymphocyte Count after First Induction Is Associated with Relapse Free Survival in Acute Myeloid Leukemia

Tatiana I. Lobanova, MD, Elena N. Parovichnikova, MD PhD, Irina V. Galtseva, MD PhD, Julia O. Davydova, Nikolay M. Kapranov, Zalina T. Fidarova, MDPhD, Olga A. Gavrilina, MDPhD, Vera V. Troitskaya, MD PhD, Valery Savchenko, MD PhD academician

Blood (2017) 130 (Supplement 1): 5087.

https://doi.org/10.1182/blood.V130.Suppl_1.5087.5087

Published: 2017

Journal Articles

Blinatumomab + Tyrosine Kinase Inhibitors with No Chemotherapy in BCR-ABL-Positive or IKZF1-Deleted or FLT3-ITD-Positive Relapsed/Refractory Acute Lymphoblastic Leukemia Patients: High Molecular Remission Rate and Toxicity Profile

Andrey N. Sokolov, MD, Elena N. Parovichnikova, MD PhD, Vera V. Troitskaya, MD PhD, Larisa A. Kuzmina, MD PhD, Irina V. Galtseva, Sergei M. Kulikov, PhD, Sergey N. Bondarenko, PhDMD, Julia O. Davidova, Nikolay M. Kapranov, Irina A. Lukyanova, MD, Tatiana I. Lobanova, MD, Ekaterina I. Usikova, MD, Ksenija I. Zarubina, MD, Valeriy G. Savchenko

Blood (2017) 130 (Supplement 1): 3884.

https://doi.org/10.1182/blood.V130.Suppl_1.3884.3884

Published: 2017

Journal Articles

Granzyme B Expression in Conventional CD4+ T-Cells Is Strongly Associated with Increased Relapse Rate during First 6 Months after Allo-HSCT

Mikhail Yu. Drokov, MD PhD, Julia O. Davydova, Larisa A. Kuzmina, MD PhD, Irina V. Galtseva, MD PhD, Nikolay M. Kapranov, Vera Vasilyeva, MD, Daria Dubnyak, MD, Olga Koroleva, MD, Ekaterina Mikhaltsova, MD, Natalia Popova, MD, Zoya Konova, MD, Elena N. Parovichnikova, MD PhD, Valery G. Savchenko, MD PhD academician

Blood (2017) 130 (Supplement 1): 1990.

https://doi.org/10.1182/blood.V130.Suppl_1.1990.1990

Published: 2017

Journal Articles

Impact of Post-Transplant High-Dose Cyclophosphamide on Reconstitution in Bone Marrow Recipients

Ekaterina Mikhaltsova, MD, Mikhail Yu. Drokov, MD PhD, Julia O. Davydova, Larisa A. Kuzmina, MD PhD, Natalia Popova, MD, Daria Dubnyak, MD, Vera Vasilyeva, MD, Olga Koroleva, MD, Zoya Konova, MD, Nikolay M. Kapranov, Irina V. Galtseva, MD PhD, Elena N. Parovichnikova, MD PhD, Valery Savchenko, MD PhD academician

Blood (2017) 130 (Supplement 1): 5485.

https://doi.org/10.1182/blood.V130.Suppl_1.5485.5485

Published: 2017

Journal Articles

Effective and Ineffective Samples of Mesenchymal Multipotent Stromal Cells Used for Acute Graft-Versus-Host Disease Prophylaxis after Allogeneic Bone Marrow Transplantation Differ in the Expression Level of HLA-DR When Co-Cultured with Activated Lymphocytes

Nataliya Petinati, PhD MD, Nikolay M. Kapranov, Yuliya O Davydova, Alexey Bigildeev, PhD, Natalia Sats, PhD, Irina Shipounova, PhD, Nina Drize, PhD, Irina V. Galtseva, MD PhD, Larisa A. Kuzmina, MD PhD, Elena N. Parovichnikova, MD PhD, Valeriy G. Savchenko

Blood (2017) 130 (Supplement 1): 5494.

https://doi.org/10.1182/blood.V130.Suppl_1.5494.5494

Published: 2017

Journal Articles

Immune Privileged Features of Multipotent Mesenchymal Stromal Cells Are Lost after Co-Cultivation with Allogeneic Lymphocytes in Vitro

Nikolay M Kapranov, Yuliya O Davydova, Nataliya Petinati, PhD, Maria V Bakshinskayte, Irina V Galtseva, Nina I. Drize, PhD, Larisa A. Kuzmina, MD PhD, Elena N. Parovichnikova, MD PhD, Valeriy G Savchenko, PhD MD

Blood (2016) 128 (22): 5722.

https://doi.org/10.1182/blood.V128.22.5722.5722

Published: 2016

Journal Articles

Granzyme B Expression in T-Regulatory Cells Is a Strong Predictor of Acute Graft-Versus-Host Disease after Day +30 in Patients with "Classic" Immunosuppression after Allo-HSCT

Mikhail Yu. Drokov, MD PhD, Elena N. Parovichnikova, MD PhD, Julia Davydova, MD, Larisa A. Kuzmina, MD PhD, Irina V Galtseva, Nikolay M Kapranov, Vera Vasilieva, Darya Dubnyak, Olga Koroleva, Ekaterina Mikhalcova, Natalia Popova, Valery G Savchenko, MD PhD academician

Blood (2016) 128 (22): 2238.

https://doi.org/10.1182/blood.V128.22.2238.2238

Published: 2016

NARROW

Platelet-Associated Antibodies By Flow Cytometry in Adult Patients with Immune Thrombocytopenia before and after Splenectomy

Stromal Precursors in the Bone Marrow of Untreated Patients with Severe and Non-Severe Aplastic Anemia Differ in the Proliferative Potential

Impact of Minimal Residual Disease Detected By Multiparameter Flow Cytometry on Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia Patients in First Complete Remission

Primary Antigen Aberrations and Immunophenotype Shifts of Blasts in AML Patients during the Treatment and at the Time of Relapse

Oligoclonal Expansion and T-Cells Subpopulations in Patients with Aplastic Anemia at Different Stages of the Disease

Alterations in the Properties of MSCs in Patients with Diffuse Large B-Cell Lymphoma (DLBCL) without Bone Marrow Involvement

The Effectiveness of Eltrombopag at the Different Stages of Aplastic Anemia and Probability of Clonal Expansion

Different Treatment Regimens, Optimal Time Points and Threshold Level While Minimal Residual Disease Evaluation in AML Patients

The MRD-Negativity Rate Measured By Flow Cytometry after the 1 st and the 2 nd Induction Course Among CR AML Patients from Different Cytogenetic Subgroups Does Not Differ Though the Morphological CR Achievement Does

Optimal Dose Horse Antithymocyte Globulin for the Treatment of Adult Patients with Aplastic Anemia: A Prospective Randomized Comparative Study

Absolute Lymphocyte Count after First Induction Is Associated with Relapse Free Survival in Acute Myeloid Leukemia

Blinatumomab + Tyrosine Kinase Inhibitors with No Chemotherapy in BCR-ABL-Positive or IKZF1-Deleted or FLT3-ITD-Positive Relapsed/Refractory Acute Lymphoblastic Leukemia Patients: High Molecular Remission Rate and Toxicity Profile

Granzyme B Expression in Conventional CD4+ T-Cells Is Strongly Associated with Increased Relapse Rate during First 6 Months after Allo-HSCT

Impact of Post-Transplant High-Dose Cyclophosphamide on Reconstitution in Bone Marrow Recipients

Effective and Ineffective Samples of Mesenchymal Multipotent Stromal Cells Used for Acute Graft-Versus-Host Disease Prophylaxis after Allogeneic Bone Marrow Transplantation Differ in the Expression Level of HLA-DR When Co-Cultured with Activated Lymphocytes

Immune Privileged Features of Multipotent Mesenchymal Stromal Cells Are Lost after Co-Cultivation with Allogeneic Lymphocytes in Vitro

Granzyme B Expression in T-Regulatory Cells Is a Strong Predictor of Acute Graft-Versus-Host Disease after Day +30 in Patients with "Classic" Immunosuppression after Allo-HSCT

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only